Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 79 entries
Sorted by: Best Match Show Resources per page
Diagnostic laparoscopy for pneumatosis intestinalis in a very elderly patient: A case report.

Annals of medicine and surgery (2012)

Ito S, Masuda T, Harada N, Matsuyama A, Hamatake M, Maeda T, Tsutsui S, Matsuda H, Mimori K, Ishida T.
PMID: 28861268
Ann Med Surg (Lond). 2017 Jul 29;21:109-113. doi: 10.1016/j.amsu.2017.07.058. eCollection 2017 Sep.

INTRODUCTION: Pneumatosis intestinalis is rare but may be associated with life-threatening intra-abdominal conditions such as intestinal ischemia or perforation. However, it can be difficult, particularly in the very elderly, to identify candidates for immediate surgical intervention.PRESENTATION OF CASE: A...

Cite
Ito S, Masuda T, Harada N, et al. Diagnostic laparoscopy for pneumatosis intestinalis in a very elderly patient: A case report. Ann Med Surg (Lond). 2017;21:109-113doi: 10.1016/j.amsu.2017.07.058.
Ito, S., Masuda, T., Harada, N., Matsuyama, A., Hamatake, M., Maeda, T., Tsutsui, S., Matsuda, H., Mimori, K., & Ishida, T. (2017). Diagnostic laparoscopy for pneumatosis intestinalis in a very elderly patient: A case report. Annals of medicine and surgery (2012), 21109-113. https://doi.org/10.1016/j.amsu.2017.07.058
Ito, Shuhei, et al. "Diagnostic laparoscopy for pneumatosis intestinalis in a very elderly patient: A case report." Annals of medicine and surgery (2012) vol. 21 (2017): 109-113. doi: https://doi.org/10.1016/j.amsu.2017.07.058
Ito S, Masuda T, Harada N, Matsuyama A, Hamatake M, Maeda T, Tsutsui S, Matsuda H, Mimori K, Ishida T. Diagnostic laparoscopy for pneumatosis intestinalis in a very elderly patient: A case report. Ann Med Surg (Lond). 2017 Jul 29;21:109-113. doi: 10.1016/j.amsu.2017.07.058. eCollection 2017 Sep. PMID: 28861268; PMCID: PMC5567747.
Copy Download .nbib Format: NLM
Combined proline-surfactant organocatalyst for the highly diastereo- and enantioselective aqueous direct cross-aldol reaction of aldehydes.

Angewandte Chemie (International ed. in English)

Hayashi Y, Aratake S, Okano T, Takahashi J, Sumiya T, Shoji M.
PMID: 16856197
Angew Chem Int Ed Engl. 2006 Aug 18;45(33):5527-9. doi: 10.1002/anie.200601156.

No abstract available.

Cite
Hayashi Y, Aratake S, Okano T, et al. Combined proline-surfactant organocatalyst for the highly diastereo- and enantioselective aqueous direct cross-aldol reaction of aldehydes. Angew Chem Int Ed Engl. 2006;45(33):5527-9doi: 10.1002/anie.200601156.
Hayashi, Y., Aratake, S., Okano, T., Takahashi, J., Sumiya, T., & Shoji, M. (2006). Combined proline-surfactant organocatalyst for the highly diastereo- and enantioselective aqueous direct cross-aldol reaction of aldehydes. Angewandte Chemie (International ed. in English), 45(33), 5527-9. https://doi.org/10.1002/anie.200601156
Hayashi, Yujiro, et al. "Combined proline-surfactant organocatalyst for the highly diastereo- and enantioselective aqueous direct cross-aldol reaction of aldehydes." Angewandte Chemie (International ed. in English) vol. 45,33 (2006): 5527-9. doi: https://doi.org/10.1002/anie.200601156
Hayashi Y, Aratake S, Okano T, Takahashi J, Sumiya T, Shoji M. Combined proline-surfactant organocatalyst for the highly diastereo- and enantioselective aqueous direct cross-aldol reaction of aldehydes. Angew Chem Int Ed Engl. 2006 Aug 18;45(33):5527-9. doi: 10.1002/anie.200601156. PMID: 16856197.
Copy Download .nbib Format: NLM
A case of different .

Journal of thoracic disease

Haratake N, Takenoyama M, Edagawa M, Shimamatsu S, Toyozawa R, Nosaki K, Hirai F, Yamaguchi M, Taguchi K, Seto T, Ichinose Y.
PMID: 29850164
J Thorac Dis. 2018 Apr;10(4):E255-E259. doi: 10.21037/jtd.2018.03.105.

We describe a 77-year-old Japanese woman who presented with three nodule shadows in three different lobes of the right lung, without evidence of lymph node metastasis or distant metastasis. All three tumors were surgically resected. The pathological diagnosis was...

Cite
Haratake N, Takenoyama M, Edagawa M, et al. A case of different . J Thorac Dis. 2018;10(4):E255-E259doi: 10.21037/jtd.2018.03.105.
Haratake, N., Takenoyama, M., Edagawa, M., Shimamatsu, S., Toyozawa, R., Nosaki, K., Hirai, F., Yamaguchi, M., Taguchi, K., Seto, T., & Ichinose, Y. (2018). A case of different . Journal of thoracic disease, 10(4), E255-E259. https://doi.org/10.21037/jtd.2018.03.105
Haratake, Naoki, et al. "A case of different ." Journal of thoracic disease vol. 10,4 (2018): E255-E259. doi: https://doi.org/10.21037/jtd.2018.03.105
Haratake N, Takenoyama M, Edagawa M, Shimamatsu S, Toyozawa R, Nosaki K, Hirai F, Yamaguchi M, Taguchi K, Seto T, Ichinose Y. A case of different . J Thorac Dis. 2018 Apr;10(4):E255-E259. doi: 10.21037/jtd.2018.03.105. PMID: 29850164; PMCID: PMC5949472.
Copy Download .nbib Format: NLM
Changes in synovial fluid biomarkers and clinical efficacy of intra-articular injections of hyaluronic acid for patients with knee osteoarthritis.

Journal of experimental orthopaedics

Kusayama Y, Akamatsu Y, Kumagai K, Kobayashi H, Aratake M, Saito T.
PMID: 26914761
J Exp Orthop. 2014 Dec;1(1):16. doi: 10.1186/s40634-014-0016-7. Epub 2014 Dec 20.

BACKGROUND: The changes in synovial fluid biomarkers after intra-articular injection of hyarulonic acid (IA HA) remain controversial. We investigate the changes in the properties of synovial fluid (SF) and clinical symptoms before the first and fifth IA HA.METHODS: A...

Cite
Kusayama Y, Akamatsu Y, Kumagai K, et al. Changes in synovial fluid biomarkers and clinical efficacy of intra-articular injections of hyaluronic acid for patients with knee osteoarthritis. J Exp Orthop. 2014;1(1):16doi: 10.1186/s40634-014-0016-7.
Kusayama, Y., Akamatsu, Y., Kumagai, K., Kobayashi, H., Aratake, M., & Saito, T. (2014). Changes in synovial fluid biomarkers and clinical efficacy of intra-articular injections of hyaluronic acid for patients with knee osteoarthritis. Journal of experimental orthopaedics, 1(1), 16. https://doi.org/10.1186/s40634-014-0016-7
Kusayama, Yoshihiro, et al. "Changes in synovial fluid biomarkers and clinical efficacy of intra-articular injections of hyaluronic acid for patients with knee osteoarthritis." Journal of experimental orthopaedics vol. 1,1 (2014): 16. doi: https://doi.org/10.1186/s40634-014-0016-7
Kusayama Y, Akamatsu Y, Kumagai K, Kobayashi H, Aratake M, Saito T. Changes in synovial fluid biomarkers and clinical efficacy of intra-articular injections of hyaluronic acid for patients with knee osteoarthritis. J Exp Orthop. 2014 Dec;1(1):16. doi: 10.1186/s40634-014-0016-7. Epub 2014 Dec 20. PMID: 26914761; PMCID: PMC4546012.
Copy Download .nbib Format: NLM
Clinical features and pathology of respiratory failure due to inflammatory myopathy induced by immune checkpoint inhibitors.

Clinical and experimental rheumatology

Aratake Y, Obata K, Nishimura K, Shindo K.
PMID: 34251330
Clin Exp Rheumatol. 2021 Jun 22; Epub 2021 Jun 22.

No abstract available.

Cite
Aratake Y, Obata K, Nishimura K, et al. Clinical features and pathology of respiratory failure due to inflammatory myopathy induced by immune checkpoint inhibitors. Clin Exp Rheumatol. 2021;
Aratake, Y., Obata, K., Nishimura, K., & Shindo, K. (2021). Clinical features and pathology of respiratory failure due to inflammatory myopathy induced by immune checkpoint inhibitors. Clinical and experimental rheumatology, .
Aratake, Yuriko, et al. "Clinical features and pathology of respiratory failure due to inflammatory myopathy induced by immune checkpoint inhibitors." Clinical and experimental rheumatology vol. (2021).
Aratake Y, Obata K, Nishimura K, Shindo K. Clinical features and pathology of respiratory failure due to inflammatory myopathy induced by immune checkpoint inhibitors. Clin Exp Rheumatol. 2021 Jun 22; Epub 2021 Jun 22. PMID: 34251330.
Copy Download .nbib Format: NLM
Recurrent vaginal intraepithelial neoplasia successfully treated with topical imiquimod: A case report.

Molecular and clinical oncology

Sasagasako N, Kosaka K, Sagae Y, Itoh K, Aratake J, Yamada K, Inayama Y, Gou R, Kawamura A, Yamanishi M, Yamanishi Y, Suzuki M, Arai K.
PMID: 32754333
Mol Clin Oncol. 2020 Sep;13(3):19. doi: 10.3892/mco.2020.2089. Epub 2020 Jul 13.

Vaginal intraepithelial neoplasia (VAIN) is a rare disease associated with human papillomavirus infection. High-grade VAIN is typically treated with either excisional or ablative therapy. However, recurrent VAIN lesions are common and these treatments cause vaginal scarring. Recent studies have...

Cite
Sasagasako N, Kosaka K, Sagae Y, et al. Recurrent vaginal intraepithelial neoplasia successfully treated with topical imiquimod: A case report. Mol Clin Oncol. 2020;13(3):19doi: 10.3892/mco.2020.2089.
Sasagasako, N., Kosaka, K., Sagae, Y., Itoh, K., Aratake, J., Yamada, K., Inayama, Y., Gou, R., Kawamura, A., Yamanishi, M., Yamanishi, Y., Suzuki, M., & Arai, K. (2020). Recurrent vaginal intraepithelial neoplasia successfully treated with topical imiquimod: A case report. Molecular and clinical oncology, 13(3), 19. https://doi.org/10.3892/mco.2020.2089
Sasagasako, Nanayo, et al. "Recurrent vaginal intraepithelial neoplasia successfully treated with topical imiquimod: A case report." Molecular and clinical oncology vol. 13,3 (2020): 19. doi: https://doi.org/10.3892/mco.2020.2089
Sasagasako N, Kosaka K, Sagae Y, Itoh K, Aratake J, Yamada K, Inayama Y, Gou R, Kawamura A, Yamanishi M, Yamanishi Y, Suzuki M, Arai K. Recurrent vaginal intraepithelial neoplasia successfully treated with topical imiquimod: A case report. Mol Clin Oncol. 2020 Sep;13(3):19. doi: 10.3892/mco.2020.2089. Epub 2020 Jul 13. PMID: 32754333; PMCID: PMC7391826.
Copy Download .nbib Format: NLM
Zinc-aggravated M1 microglia regulate astrocytic engulfment via P2×7 receptors.

Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS)

Hamada T, Aratake T, Higashi Y, Ueba Y, Shimizu T, Shimizu S, Yawata T, Ueba T, Nakamura R, Akizawa T, Fujieda M, Saito M.
PMID: 32353820
J Trace Elem Med Biol. 2020 Apr 11;61:126518. doi: 10.1016/j.jtemb.2020.126518. Epub 2020 Apr 11.

BACKGROUND: Glial cells such as astrocytes and microglia play an important role in the central nervous system via communication between these glial cells. Activated microglia can exhibit either the inflammatory M1 phenotype or the anti-inflammatory M2 phenotype, which influences...

Cite
Hamada T, Aratake T, Higashi Y, et al. Zinc-aggravated M1 microglia regulate astrocytic engulfment via P2×7 receptors. J Trace Elem Med Biol. 2020;61:126518doi: 10.1016/j.jtemb.2020.126518.
Hamada, T., Aratake, T., Higashi, Y., Ueba, Y., Shimizu, T., Shimizu, S., Yawata, T., Ueba, T., Nakamura, R., Akizawa, T., Fujieda, M., & Saito, M. (2020). Zinc-aggravated M1 microglia regulate astrocytic engulfment via P2×7 receptors. Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS), 61126518. https://doi.org/10.1016/j.jtemb.2020.126518
Hamada, Tomoya, et al. "Zinc-aggravated M1 microglia regulate astrocytic engulfment via P2×7 receptors." Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS) vol. 61 (2020): 126518. doi: https://doi.org/10.1016/j.jtemb.2020.126518
Hamada T, Aratake T, Higashi Y, Ueba Y, Shimizu T, Shimizu S, Yawata T, Ueba T, Nakamura R, Akizawa T, Fujieda M, Saito M. Zinc-aggravated M1 microglia regulate astrocytic engulfment via P2×7 receptors. J Trace Elem Med Biol. 2020 Apr 11;61:126518. doi: 10.1016/j.jtemb.2020.126518. Epub 2020 Apr 11. PMID: 32353820.
Copy Download .nbib Format: NLM
Assessment of the albumin-bilirubin grade as a prognostic factor in patients with non-small-cell lung cancer receiving anti-PD-1-based therapy.

ESMO open

Takada K, Takamori S, Shimokawa M, Toyokawa G, Shimamatsu S, Hirai F, Tagawa T, Okamoto T, Hamatake M, Tsuchiya-Kawano Y, Otsubo K, Inoue K, Yoneshima Y, Tanaka K, Okamoto I, Nakanishi Y, Mori M.
PMID: 34942439
ESMO Open. 2021 Dec 20;7(1):100348. doi: 10.1016/j.esmoop.2021.100348. Epub 2021 Dec 20.

INTRODUCTION: The albumin-bilirubin (ALBI) grade is a novel indicator of the liver function. Some studies showed that the ALBI grade was a prognostic and predictive biomarker for the efficacy of chemotherapy in cancer patients. The association between the ALBI...

Cite
Takada K, Takamori S, Shimokawa M, et al. Assessment of the albumin-bilirubin grade as a prognostic factor in patients with non-small-cell lung cancer receiving anti-PD-1-based therapy. ESMO Open. 2021;7(1):100348doi: 10.1016/j.esmoop.2021.100348.
Takada, K., Takamori, S., Shimokawa, M., Toyokawa, G., Shimamatsu, S., Hirai, F., Tagawa, T., Okamoto, T., Hamatake, M., Tsuchiya-Kawano, Y., Otsubo, K., Inoue, K., Yoneshima, Y., Tanaka, K., Okamoto, I., Nakanishi, Y., & Mori, M. (2021). Assessment of the albumin-bilirubin grade as a prognostic factor in patients with non-small-cell lung cancer receiving anti-PD-1-based therapy. ESMO open, 7(1), 100348. https://doi.org/10.1016/j.esmoop.2021.100348
Takada, K, et al. "Assessment of the albumin-bilirubin grade as a prognostic factor in patients with non-small-cell lung cancer receiving anti-PD-1-based therapy." ESMO open vol. 7,1 (2021): 100348. doi: https://doi.org/10.1016/j.esmoop.2021.100348
Takada K, Takamori S, Shimokawa M, Toyokawa G, Shimamatsu S, Hirai F, Tagawa T, Okamoto T, Hamatake M, Tsuchiya-Kawano Y, Otsubo K, Inoue K, Yoneshima Y, Tanaka K, Okamoto I, Nakanishi Y, Mori M. Assessment of the albumin-bilirubin grade as a prognostic factor in patients with non-small-cell lung cancer receiving anti-PD-1-based therapy. ESMO Open. 2021 Dec 20;7(1):100348. doi: 10.1016/j.esmoop.2021.100348. Epub 2021 Dec 20. PMID: 34942439.
Copy Download .nbib Format: NLM
Peptidyl-prolyl cis-trans isomerase A participates in the selenium transport into the rat brain.

Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry

Yoshida S, Yamamoto A, Masumoto H, Fuchigami T, Toriba A, Haratake M, Nakayama M.
PMID: 34550449
J Biol Inorg Chem. 2021 Dec;26(8):933-945. doi: 10.1007/s00775-021-01903-6. Epub 2021 Sep 22.

Selenium, an essential micronutrient, plays vital roles in the brain. Selenoprotein P (SELENOP), a major plasma selenoprotein, is thought to transport selenium to the brain. However, Selenop-knockout mice fed a diet containing an adequate amount of selenium shows no...

Cite
Yoshida S, Yamamoto A, Masumoto H, et al. Peptidyl-prolyl cis-trans isomerase A participates in the selenium transport into the rat brain. J Biol Inorg Chem. 2021;26(8):933-945doi: 10.1007/s00775-021-01903-6.
Yoshida, S., Yamamoto, A., Masumoto, H., Fuchigami, T., Toriba, A., Haratake, M., & Nakayama, M. (2021). Peptidyl-prolyl cis-trans isomerase A participates in the selenium transport into the rat brain. Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry, 26(8), 933-945. https://doi.org/10.1007/s00775-021-01903-6
Yoshida, Sakura, et al. "Peptidyl-prolyl cis-trans isomerase A participates in the selenium transport into the rat brain." Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry vol. 26,8 (2021): 933-945. doi: https://doi.org/10.1007/s00775-021-01903-6
Yoshida S, Yamamoto A, Masumoto H, Fuchigami T, Toriba A, Haratake M, Nakayama M. Peptidyl-prolyl cis-trans isomerase A participates in the selenium transport into the rat brain. J Biol Inorg Chem. 2021 Dec;26(8):933-945. doi: 10.1007/s00775-021-01903-6. Epub 2021 Sep 22. PMID: 34550449.
Copy Download .nbib Format: NLM
Optimizing Sequential Treatment With EGFR Tyrosine Kinase Inhibitor With a Simulation of the T790M Mutation Rate in .

JTO clinical and research reports

Haratake N, Misumi T, Yamanaka T, Seto T.
PMID: 34589964
JTO Clin Res Rep. 2020 Aug 21;1(4):100085. doi: 10.1016/j.jtocrr.2020.100085. eCollection 2020 Nov.

INTRODUCTION: The mutation rate of T790M might change the effective therapeutic sequence of EGFR tyrosine kinase inhibitors (TKIs). This simulation estimates the T790M positivity rate required for first-line first- or second-generation EGFR TKI to exceed overall progression-free survival (PFS)...

Cite
Haratake N, Misumi T, Yamanaka T, et al. Optimizing Sequential Treatment With EGFR Tyrosine Kinase Inhibitor With a Simulation of the T790M Mutation Rate in . JTO Clin Res Rep. 2020;1(4):100085doi: 10.1016/j.jtocrr.2020.100085.
Haratake, N., Misumi, T., Yamanaka, T., & Seto, T. (2020). Optimizing Sequential Treatment With EGFR Tyrosine Kinase Inhibitor With a Simulation of the T790M Mutation Rate in . JTO clinical and research reports, 1(4), 100085. https://doi.org/10.1016/j.jtocrr.2020.100085
Haratake, Naoki, et al. "Optimizing Sequential Treatment With EGFR Tyrosine Kinase Inhibitor With a Simulation of the T790M Mutation Rate in ." JTO clinical and research reports vol. 1,4 (2020): 100085. doi: https://doi.org/10.1016/j.jtocrr.2020.100085
Haratake N, Misumi T, Yamanaka T, Seto T. Optimizing Sequential Treatment With EGFR Tyrosine Kinase Inhibitor With a Simulation of the T790M Mutation Rate in . JTO Clin Res Rep. 2020 Aug 21;1(4):100085. doi: 10.1016/j.jtocrr.2020.100085. eCollection 2020 Nov. PMID: 34589964; PMCID: PMC8474446.
Copy Download .nbib Format: NLM
Assessment of the albumin-bilirubin grade as a prognostic factor in patients with non-small-cell lung cancer receiving anti-PD-1-based therapy.

ESMO open

Takada K, Takamori S, Shimokawa M, Toyokawa G, Shimamatsu S, Hirai F, Tagawa T, Okamoto T, Hamatake M, Tsuchiya-Kawano Y, Otsubo K, Inoue K, Yoneshima Y, Tanaka K, Okamoto I, Nakanishi Y, Mori M.
PMID: 34942439
ESMO Open. 2021 Dec 20;7(1):100348. doi: 10.1016/j.esmoop.2021.100348. Epub 2021 Dec 20.

INTRODUCTION: The albumin-bilirubin (ALBI) grade is a novel indicator of the liver function. Some studies showed that the ALBI grade was a prognostic and predictive biomarker for the efficacy of chemotherapy in cancer patients. The association between the ALBI...

Cite
Takada K, Takamori S, Shimokawa M, et al. Assessment of the albumin-bilirubin grade as a prognostic factor in patients with non-small-cell lung cancer receiving anti-PD-1-based therapy. ESMO Open. 2021;7(1):100348doi: 10.1016/j.esmoop.2021.100348.
Takada, K., Takamori, S., Shimokawa, M., Toyokawa, G., Shimamatsu, S., Hirai, F., Tagawa, T., Okamoto, T., Hamatake, M., Tsuchiya-Kawano, Y., Otsubo, K., Inoue, K., Yoneshima, Y., Tanaka, K., Okamoto, I., Nakanishi, Y., & Mori, M. (2021). Assessment of the albumin-bilirubin grade as a prognostic factor in patients with non-small-cell lung cancer receiving anti-PD-1-based therapy. ESMO open, 7(1), 100348. https://doi.org/10.1016/j.esmoop.2021.100348
Takada, K, et al. "Assessment of the albumin-bilirubin grade as a prognostic factor in patients with non-small-cell lung cancer receiving anti-PD-1-based therapy." ESMO open vol. 7,1 (2021): 100348. doi: https://doi.org/10.1016/j.esmoop.2021.100348
Takada K, Takamori S, Shimokawa M, Toyokawa G, Shimamatsu S, Hirai F, Tagawa T, Okamoto T, Hamatake M, Tsuchiya-Kawano Y, Otsubo K, Inoue K, Yoneshima Y, Tanaka K, Okamoto I, Nakanishi Y, Mori M. Assessment of the albumin-bilirubin grade as a prognostic factor in patients with non-small-cell lung cancer receiving anti-PD-1-based therapy. ESMO Open. 2021 Dec 20;7(1):100348. doi: 10.1016/j.esmoop.2021.100348. Epub 2021 Dec 20. PMID: 34942439; PMCID: PMC8695291.
Copy Download .nbib Format: NLM
Prognostic impact of the Controlling Nutritional Status score in patients with non-small cell lung cancer treated with pembrolizumab.

Journal of thoracic disease

Ohba T, Takamori S, Toyozawa R, Nosaki K, Umeyama Y, Haratake N, Miura N, Yamaguchi M, Taguchi K, Seto T, Shimokawa M, Takenoyama M.
PMID: 31656648
J Thorac Dis. 2019 Sep;11(9):3757-3768. doi: 10.21037/jtd.2019.09.29.

BACKGROUND: Pembrolizumab, an anti-programmed cell death-1 (PD-1) monoclonal antibody, has been shown to yield a durable response and significant survival benefit in some non-small cell lung cancer (NSCLC) patients. Recent studies have shown that the Controlling Nutritional Status (CONUT)...

Cite
Ohba T, Takamori S, Toyozawa R, et al. Prognostic impact of the Controlling Nutritional Status score in patients with non-small cell lung cancer treated with pembrolizumab. J Thorac Dis. 2019;11(9):3757-3768doi: 10.21037/jtd.2019.09.29.
Ohba, T., Takamori, S., Toyozawa, R., Nosaki, K., Umeyama, Y., Haratake, N., Miura, N., Yamaguchi, M., Taguchi, K., Seto, T., Shimokawa, M., & Takenoyama, M. (2019). Prognostic impact of the Controlling Nutritional Status score in patients with non-small cell lung cancer treated with pembrolizumab. Journal of thoracic disease, 11(9), 3757-3768. https://doi.org/10.21037/jtd.2019.09.29
Ohba, Taro, et al. "Prognostic impact of the Controlling Nutritional Status score in patients with non-small cell lung cancer treated with pembrolizumab." Journal of thoracic disease vol. 11,9 (2019): 3757-3768. doi: https://doi.org/10.21037/jtd.2019.09.29
Ohba T, Takamori S, Toyozawa R, Nosaki K, Umeyama Y, Haratake N, Miura N, Yamaguchi M, Taguchi K, Seto T, Shimokawa M, Takenoyama M. Prognostic impact of the Controlling Nutritional Status score in patients with non-small cell lung cancer treated with pembrolizumab. J Thorac Dis. 2019 Sep;11(9):3757-3768. doi: 10.21037/jtd.2019.09.29. PMID: 31656648; PMCID: PMC6790442.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 79 entries